Capricor Therapeutics (CAPR) Prepaid Assets (2010 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Prepaid Assets of $4.5 million for Q1 2026, up 216.81% year-over-year from $1.4 million in Q1 2025, and down 5.74% quarter-over-quarter from $4.8 million in Q4 2025.
Capricor Therapeutics (CAPR) Prepaid Assets (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 216.81% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (up 216.81% YoY), while the FY2025 annual figure was $4.8 million, up 216.59% from the prior year.
- Prepaid Assets for Q1 2026 stood at $4.5 million, down from $4.8 million in the prior quarter.
- The five-year high for Prepaid Assets was $4.8 million in Q4 2025, with the low at $343684.0 in Q3 2022.
- The 5-year median for Prepaid Assets is $943246.0 (2022), against an average of $1.4 million.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets slipped 20.69% in 2022, then jumped 504.19% in 2025.
- Capricor Therapeutics' Prepaid Assets stood at $919892.0 in 2022, then climbed by 8.25% to $995776.0 in 2023, then soared by 50.73% to $1.5 million in 2024, then jumped by 216.59% to $4.8 million in 2025, then decreased by 5.74% to $4.5 million in 2026.
- Business Quant data shows CAPR's Prepaid Assets at $4.5 million in Q1 2026, $4.8 million in Q4 2025, and $2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.48 Mn |
| Dec 31, 2025 | 4.75 Mn |
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 385,065.00 |
| Jun 30, 2024 | 837,218.00 |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 995,776.00 |
| Sep 30, 2023 | 458,417.00 |
| Jun 30, 2023 | 583,835.00 |
| Mar 31, 2023 | 875,092.00 |
| Dec 31, 2022 | 919,892.00 |
| Sep 30, 2022 | 343,684.00 |
| Jun 30, 2022 | 659,269.00 |
| Mar 31, 2022 | 943,246.00 |
| Dec 31, 2021 | 1.16 Mn |
| Sep 30, 2021 | 278,909.00 |
| Jun 30, 2021 | 653,336.00 |